76222610
Mar 8, 2001
Jan 6, 2004
pharmaceutical preparations, namely, cell adhesion modulating agents for use in the treatment of cancer, endometriosis, macular degeneration and other [angiogensis-dependent] * angiogenesis-dependent * conditions, multiple sclerosis and other demyelinating diseases, spinal cord injury, obesity, and hair loss; therapeutic preparations, namely, cell adhesion modulating agents for use in drug delivery systems for facilitating the transmission of agents through human tissue; and diagnostic preparations, namely, cell adhesion modulating agents for use in medical diagnostic reagents
Pharmaceuticals